329 related articles for article (PubMed ID: 34284037)
21. Assessment of 135 794 Pediatric Patients Tested for Severe Acute Respiratory Syndrome Coronavirus 2 Across the United States.
Bailey LC; Razzaghi H; Burrows EK; Bunnell HT; Camacho PEF; Christakis DA; Eckrich D; Kitzmiller M; Lin SM; Magnusen BC; Newland J; Pajor NM; Ranade D; Rao S; Sofela O; Zahner J; Bruno C; Forrest CB
JAMA Pediatr; 2021 Feb; 175(2):176-184. PubMed ID: 33226415
[TBL] [Abstract][Full Text] [Related]
22. Effects of SARS-CoV-2 infection on incidence and treatment strategies of hepatocellular carcinoma in people with chronic liver disease.
Mak LY; Chung MSH; Li X; Lai FTT; Wan EYF; Chui CSL; Cheng FWT; Chan EWY; Cheung CL; Au ICH; Xiong X; Seto WK; Yuen MF; Wong CKH; Wong ICK
World J Hepatol; 2024 Feb; 16(2):211-228. PubMed ID: 38495273
[TBL] [Abstract][Full Text] [Related]
23. Hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting (LIBERTY): A structured summary of a study protocol for a randomised controlled trial.
Vainio PJ; Hietasalo P; Koivisto AL; Kääriäinen S; Turunen J; Virtala M; Vuorinen J; Scheinin M
Trials; 2021 Jan; 22(1):44. PubMed ID: 33430933
[TBL] [Abstract][Full Text] [Related]
24. Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort study.
Patone M; Thomas K; Hatch R; Tan PS; Coupland C; Liao W; Mouncey P; Harrison D; Rowan K; Horby P; Watkinson P; Hippisley-Cox J
Lancet Infect Dis; 2021 Nov; 21(11):1518-1528. PubMed ID: 34171232
[TBL] [Abstract][Full Text] [Related]
25. Effect of COVID-19 on patients with compensated chronic liver diseases.
Ji D; Zhang D; Yang T; Mu J; Zhao P; Xu J; Li C; Cheng G; Wang Y; Chen Z; Qin E; Lau G
Hepatol Int; 2020 Sep; 14(5):701-710. PubMed ID: 32734407
[TBL] [Abstract][Full Text] [Related]
26. SARS-CoV-2 infection and mortality during the first epidemic wave in Madurai, south India: a prospective, active surveillance study.
Laxminarayan R; B CM; G VT; Arjun Kumar KV; Wahl B; Lewnard JA
Lancet Infect Dis; 2021 Dec; 21(12):1665-1676. PubMed ID: 34399090
[TBL] [Abstract][Full Text] [Related]
27. Risk of severe COVID-19 and mortality in patients with established chronic liver disease: a nationwide matched cohort study.
Simon TG; Hagström H; Sharma R; Söderling J; Roelstraete B; Larsson E; Ludvigsson JF
BMC Gastroenterol; 2021 Nov; 21(1):439. PubMed ID: 34814851
[TBL] [Abstract][Full Text] [Related]
28. Safety and Immunogenicity of SARS-CoV-2 Vaccines in Patients With Chronic Liver Diseases (CHESS-NMCID 2101): A Multicenter Study.
Ai J; Wang J; Liu D; Xiang H; Guo Y; Lv J; Zhang Q; Li J; Zhang X; Li Q; Liang J; Guo X; Feng Y; Liu L; Zhang X; Qin W; Wang X; Rao W; Zhang Q; Tian Q; Zhang Y; Xie F; Jiang S; Yan Y; Qiu Y; Wu H; Hou Z; Zhang N; Zhang A; Ji J; Yang J; Huang J; Zhao Z; Gu Y; Bian L; Zhang Z; Zou S; Ji H; Ge G; Du X; Hou A; Zhu Y; Cong Q; Xu J; Zu H; Wang Y; Yan Z; Yan X; BianBa Y; Ci Q; Zhang L; Yang S; Gao X; Zhong L; He S; Liu C; Huang Y; Liu Y; Xu D; Zhu Q; Xu X; Lv M; Zhang W; Qi X
Clin Gastroenterol Hepatol; 2022 Jul; 20(7):1516-1524.e2. PubMed ID: 34942370
[TBL] [Abstract][Full Text] [Related]
29. COVID-19 mortality in cirrhosis is determined by cirrhosis-associated comorbidities and extrahepatic organ failure: Results from the multinational LEOSS registry.
Brozat JF; Hanses F; Haelberger M; Stecher M; Dreher M; Tometten L; Ruethrich MM; Vehreschild JJ; Trautwein C; Borgmann S; Vehreschild MJGT; Jakob CEM; Stallmach A; Wille K; Hellwig K; Isberner N; Reuken PA; Geisler F; Nattermann J; Bruns T;
United European Gastroenterol J; 2022 May; 10(4):409-424. PubMed ID: 35482663
[TBL] [Abstract][Full Text] [Related]
30. High rates of 30-day mortality in patients with cirrhosis and COVID-19.
Iavarone M; D'Ambrosio R; Soria A; Triolo M; Pugliese N; Del Poggio P; Perricone G; Massironi S; Spinetti A; Buscarini E; Viganò M; Carriero C; Fagiuoli S; Aghemo A; Belli LS; Lucà M; Pedaci M; Rimondi A; Rumi MG; Invernizzi P; Bonfanti P; Lampertico P
J Hepatol; 2020 Nov; 73(5):1063-1071. PubMed ID: 32526252
[TBL] [Abstract][Full Text] [Related]
31. SARS-CoV-2 Infections Among Patients With Liver Disease and Liver Transplantation Who Received COVID-19 Vaccination.
Moon AM; Webb GJ; García-Juárez I; Kulkarni AV; Adali G; Wong DK; Lusina B; Dalekos GN; Masson S; Shore BM; Barnes E; Barritt AS; Marjot T
Hepatol Commun; 2022 Apr; 6(4):889-897. PubMed ID: 34708575
[TBL] [Abstract][Full Text] [Related]
32. Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study.
Webb GJ; Marjot T; Cook JA; Aloman C; Armstrong MJ; Brenner EJ; Catana MA; Cargill T; Dhanasekaran R; García-Juárez I; Hagström H; Kennedy JM; Marshall A; Masson S; Mercer CJ; Perumalswami PV; Ruiz I; Thaker S; Ufere NN; Barnes E; Barritt AS; Moon AM
Lancet Gastroenterol Hepatol; 2020 Nov; 5(11):1008-1016. PubMed ID: 32866433
[TBL] [Abstract][Full Text] [Related]
33. Chronic Liver Disease and Cirrhosis are Associated with Worse Outcomes Following SARS-CoV-2 Infection.
Wong RJ; Zhang Y; Thamer M
J Clin Exp Hepatol; 2023; 13(4):592-600. PubMed ID: 36777086
[TBL] [Abstract][Full Text] [Related]
34. Poor outcomes in patients with cirrhosis and Corona Virus Disease-19.
Shalimar ; Elhence A; Vaishnav M; Kumar R; Pathak P; Soni KD; Aggarwal R; Soneja M; Jorwal P; Kumar A; Khanna P; Singh AK; Biswas A; Nischal N; Dar L; Choudhary A; Rangarajan K; Mohan A; Acharya P; Nayak B; Gunjan D; Saraya A; Mahapatra S; Makharia G; Trikha A; Garg P
Indian J Gastroenterol; 2020 Jun; 39(3):285-291. PubMed ID: 32803716
[TBL] [Abstract][Full Text] [Related]
35. Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination: national prospective cohort study.
Hippisley-Cox J; Coupland CA; Mehta N; Keogh RH; Diaz-Ordaz K; Khunti K; Lyons RA; Kee F; Sheikh A; Rahman S; Valabhji J; Harrison EM; Sellen P; Haq N; Semple MG; Johnson PWM; Hayward A; Nguyen-Van-Tam JS
BMJ; 2021 Sep; 374():n2244. PubMed ID: 34535466
[TBL] [Abstract][Full Text] [Related]
36. Risk of mortality in people with chronic liver diseases hospitalized for Coronavirus disease of 2019 (COVID-19) in a tertiary hospital in Lombardy, Italy.
Ranzenigo M; Ceccarelli D; Galli L; Bertoni C; Siribelli A; Messina E; Hasson H; Lolatto R; Castagna A; Uberti-Foppa C; Morsica G
New Microbiol; 2023 Sep; 46(3):296-302. PubMed ID: 37747475
[TBL] [Abstract][Full Text] [Related]
37. Outcomes of COVID-19 in Patients With Cancer: Report From the National COVID Cohort Collaborative (N3C).
Sharafeldin N; Bates B; Song Q; Madhira V; Yan Y; Dong S; Lee E; Kuhrt N; Shao YR; Liu F; Bergquist T; Guinney J; Su J; Topaloglu U
J Clin Oncol; 2021 Jul; 39(20):2232-2246. PubMed ID: 34085538
[TBL] [Abstract][Full Text] [Related]
38. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients.
Taquet M; Sillett R; Zhu L; Mendel J; Camplisson I; Dercon Q; Harrison PJ
Lancet Psychiatry; 2022 Oct; 9(10):815-827. PubMed ID: 35987197
[TBL] [Abstract][Full Text] [Related]
39. A real-world experience of SARS-CoV-2 infection in a tertiary referral centre of Montréal: Unexpected low prevalence and low mortality.
Ruiz I; Huard G; Fournier C; Bissonnette J; Castel H; Giard JM; Villeneuve JP; Fenyves D; Marleau D; Willems B; Corsilli D; Correal F; Ferreira V; Martel D; Mathieu A; Vincent C; Bilodeau M
Can Liver J; 2021; 4(4):391-400. PubMed ID: 35989892
[TBL] [Abstract][Full Text] [Related]
40. Chronic comorbidities and clinical outcomes in patients with and without COVID-19: a large population-based study using national administrative healthcare open data of Mexico.
Martos-Benítez FD; Soler-Morejón CD; García-Del Barco D
Intern Emerg Med; 2021 Sep; 16(6):1507-1517. PubMed ID: 33411264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
